US Drug Recall Register

FDA Drug Recalls

1,463 recalls · Class I, newest first

Class I · High risk Terminated

XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box

Reason Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety…

Dolphin Intertrade Corporation D-1250-2014